ReviewDer Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete2015
[Local combination therapy of inflammatory dermatomycosis: A review of recommendations in national and international guidelines].
Review in Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Article
- Updates on Genital Dermatophytosis.Clinical, cosmetic and investigational dermatology · 2020Review
- [Topical therapy of the scalp].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2017Review
- [Clotrimazole and ciclopirox olamine respectively in combination with methylprednisolone aceponate as extemporaneous formulations].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2017Article
- [Treatment of dermatoses : Significance and use of glucocorticoids in fixed combination with antifungals].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2016Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDermatomycosis, caused by fungi or dermatophytes is often accompanied by considerable inflammatory changes and is, therefore, of great clinical significance. Hence, it is reasonable to eliminate both the pathogen and all signs of inflammation by applying a drug combination of antimycotic and corticosteroid.
objectivesHow do national and international guidelines support this kind of therapy? Does consensus prevail, or are there a variety of recommendations? MATERIALS AND
methodsThe present article uses the internationally recognized scientific search method to evaluate pharmaceuticals and discusses the results of the international recommendations.
resultsThe use of a corticosteroid/antimycotic combination therapy for the treatment of various types of inflammatory dermatomycosis is explicitly recommended by national and international guidelines. Although two significant German guidelines for treatment of dermatomycoses do not include usage of combination preparations, in view of their current relevance, however, their adaptation to international recommendations appears to make sense.
Indexed as
Identifiers
25939891What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.